The PE Ratio as of December 2024 (TTM) for Coya Therapeutics, Inc. (COYA) is -8.32

According to Coya Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -8.32. This represents a change of -33910.09% compared to the average of 0.02 of the last 4 quarters.

Coya Therapeutics, Inc. (COYA) Historical PE Ratio (quarterly & annually)

How has COYA PE Ratio performed in the past?

The mean historical PE Ratio of Coya Therapeutics, Inc. over the last ten years is -20.51. The current -8.32 PE Ratio has changed 3.96% with respect to the historical average. Over the past ten years (40 quarters), COYA's PE Ratio was at its highest in in the December 2023 quarter at 21.08. The PE Ratio was at its lowest in in the September 2021 quarter at -8.31.

Coya Therapeutics, Inc. (COYA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Coya Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Coya Therapeutics, Inc. (COYA) Average PE Ratio

How has COYA PE Ratio performed in the past?

The current PE Ratio of Coya Therapeutics, Inc. (COYA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Coya Therapeutics, Inc. (COYA) PE Ratio vs. Peers

How is COYA’s PE Ratio compared to its peers?

Coya Therapeutics, Inc.’s PE Ratio is less than Cue Biopharma, Inc. (-1.19), less than Lantern Pharma Inc. (-1.75), greater than Fennec Pharmaceuticals Inc. (-139.35), less than Eliem Therapeutics, Inc. (0), less than Acumen Pharmaceuticals, Inc. (-1.30), less than Inozyme Pharma, Inc. (-1.90), less than Terns Pharmaceuticals, Inc. (-5.11), greater than Day One Biopharmaceuticals, Inc. (-14.44), less than Galera Therapeutics, Inc. (-0.09), less than Cognition Therapeutics, Inc. (-0.73), less than TFF Pharmaceuticals, Inc. (-0.02), less than TScan Therapeutics, Inc. (-3.16), less than Dermata Therapeutics, Inc. (-0.18), greater than NewAmsterdam Pharma Company N.V. (-13.28), greater than Centessa Pharmaceuticals plc (-11.88), less than Sutro Biopharma, Inc. (-1.25), less than Opthea Limited (-1.15), less than HilleVax, Inc. (-0.62), less than Gain Therapeutics, Inc. (-1.95), less than aTyr Pharma, Inc. (-2.33), less than IN8bio, Inc. (-0.35),

Build a custom stock screener for Coya Therapeutics, Inc. (COYA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Coya Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Coya Therapeutics, Inc. (COYA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Coya Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.